Insider Transactions last 24 months for Apogee Therapeutics Inc.  -  NSDQ: APGE

 
Transactions
All Buy Sell Option Exercise
Filer's Name
Relationship/
Title
Trans.
Date
Trans. Type
Ownership Type
Security Type
Shares
Price
Trans.
Value
Total Shares Owned
Henderson JaneChief Financial Officer03/25/2026DSDirectCOM2,000$85.00$170,000.00179,371
Henderson Michael ThomasChief Executive Officer03/11/2026DSDirectCOM3,418$75.86$259,289.481,152,987
Henderson Michael ThomasChief Executive Officer03/11/2026DSDirectCOM8,219$74.83$615,027.771,156,405
Henderson Michael ThomasChief Executive Officer03/11/2026DSDirectCOM8,363$74.29$621,287.271,164,624
Dambkowski CarlChief Medical Officer03/04/2026DSDirectCOM200$73.26$14,652.00209,773
Dambkowski CarlChief Medical Officer03/04/2026DSDirectCOM2,075$71.98$149,358.50209,973
Dambkowski CarlChief Medical Officer03/04/2026DSDirectCOM3,225$70.33$226,814.25212,048
Dambkowski CarlChief Medical Officer03/04/2026AMDirectCOM4,125$22.86$94,297.50215,273
Henderson JaneChief Financial Officer03/02/2026DSDirectCOM406$71.66$29,093.96181,371
Henderson JaneChief Financial Officer03/02/2026DSDirectCOM994$70.45$70,027.30181,777
Henderson JaneChief Financial Officer03/02/2026DSDirectCOM300$69.43$20,829.00182,771
Henderson JaneChief Financial Officer03/02/2026DSDirectCOM300$68.27$20,481.00183,071
Henderson Michael ThomasChief Executive Officer02/11/2026DSDirectCOM955$64.99$62,065.451,172,987
Henderson Michael ThomasChief Executive Officer02/11/2026DSDirectCOM7,551$63.73$481,225.231,173,942
Henderson Michael ThomasChief Executive Officer02/11/2026DSDirectCOM11,494$62.96$723,662.241,181,493
Dambkowski CarlChief Medical Officer02/04/2026DSDirectCOM200$68.94$13,788.00211,148
Dambkowski CarlChief Medical Officer02/04/2026DSDirectCOM100$67.88$6,788.00211,348
Dambkowski CarlChief Medical Officer02/04/2026DSDirectCOM1,299$66.85$86,838.15211,448
Dambkowski CarlChief Medical Officer02/04/2026DSDirectCOM1,420$65.83$93,478.60212,747
Dambkowski CarlChief Medical Officer02/04/2026DSDirectCOM2,481$64.88$160,967.28214,167
Dambkowski CarlChief Medical Officer02/04/2026AMDirectCOM4,125$22.86$94,297.50216,648
Henderson JaneChief Financial Officer02/02/2026DSDirectCOM100$66.89$6,689.00183,371
Henderson JaneChief Financial Officer02/02/2026DSDirectCOM1,108$66.15$73,294.20183,471
Henderson JaneChief Financial Officer02/02/2026DSDirectCOM792$65.21$51,646.32184,579
Fairmount Funds Management LlcDirector01/22/2026DSIndirectCOM1,750,000$76.30$133,525,000.00298,647
1   2  3  4  5  Next Last  You are at page 1 of 5 pages
Transaction Type Key
First letter: A = Acquired, D = Disposed
Second letter:
A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust 		Export Table Data to Excel Send to Excel